M4MM
Kasvu Therapeutics Raises €30M for Next Generation Neuroplasticity Drugs
HELSINKI – Kasvu Therapeutics, a three-year-old spinout from the University of Helsinki, closed a €30 million Series A to advance its lead compound toward clinical development. The round was led by Hadean Ventures, with participation ...
Aurora Hits Curaleaf with Regulatory Complaint Over Hostile Bid
EDMONTON – Aurora Cannabis Inc. filed an application with the Alberta Securities Commission (ASC), asking the regulator to order Curaleaf Holdings Inc. to correct several alleged deficiencies in its hostile takeover bid circular – or ...
RIOCOCO Opens Its Largest Single Production Site in Sri Lanka
KATUPOTHA – RIOCOCO, one of the world's leading manufacturers of coconut coir growing substrates, has opened the largest single coco coir production facility in Sri Lanka, built at its existing base in Katupotha and operational ...
Curaleaf Escalates Aurora Fight, Asks Alberta Regulator to Freeze Share Sales
STAMFORD – Curaleaf Holdings Inc. submitted a formal application to the Alberta Securities Commission (ASC), seeking to halt Aurora Cannabis's at-the-market share issuance program while Curaleaf's offer to acquire all outstanding Aurora shares remains outstanding. ...
Dutch Cannabis Supply Pilot Delivers Lower Prices and a Fuller Shelf
AMSTERDAM – A report published by the Trimbos Institute, RAND Europe, and Breuer&Intraval compared ten municipalities where coffeeshops sell exclusively licensed-grown Сannabis against ten operating under the country's traditional tolerance policy. The program launched April ...
Cannara Secures Upgraded $80M Credit Line
MONTREAL – Cannara Biotech Inc. announced that its operating subsidiary has entered into an amended and restated syndicated credit agreement with Bank of Montreal (BMO) and The Toronto-Dominion Bank (TD), establishing $80 million in committed ...
Virginia Unveils Draft Rules for Adult-Use Cannabis Market
RICHMOND – The Virginia Cannabis Control Authority (CCA) released an 80-plus-page draft regulatory framework for the state's forthcoming adult-use market – the first detailed set of proposed rules since the General Assembly authorized commercial sales ...
Kasvu Therapeutics Raises €30M for Next Generation Neuroplasticity Drugs
HELSINKI – Kasvu Therapeutics, a three-year-old spinout from the University of Helsinki, closed a €30 million Series A to advance its lead compound toward clinical development. The round was led by Hadean Ventures, with participation ...
Aurora Hits Curaleaf with Regulatory Complaint Over Hostile Bid
EDMONTON – Aurora Cannabis Inc. filed an application with the Alberta Securities Commission (ASC), asking the regulator to order Curaleaf Holdings Inc. to correct several alleged deficiencies in its hostile takeover bid circular – or ...
RIOCOCO Opens Its Largest Single Production Site in Sri Lanka
KATUPOTHA – RIOCOCO, one of the world's leading manufacturers of coconut coir growing substrates, has opened the largest single coco coir production facility in Sri Lanka, built at its existing base in Katupotha and operational ...
IRS and Treasury Move to Clarify Cannabis Tax Rules
WASHINGTON – The U.S. Department of the Treasury and the Internal Revenue Service made an announcement, confirming they will issue formal guidance to address the federal tax consequences of a Department of Justice order that ...
DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential step on Cannabis policy in decades, as Acting Attorney General Todd Blanche formally signed an order moving state-licensed medical Cannabis from Schedule I to Schedule ...
Safe Harbor Targets Retirement Gap in Cannabis Workforce
DENVER – Safe Harbor Financial is extending its reach deeper into workforce benefits, introducing a pooled employer 401(k) plan designed for Cannabis operators that have long struggled to access conventional retirement services. The new offering, ...
AtaiBeckley Reports Expanded Phase 2a Data for EMP-01 in Social Anxiety Disorder
NEW YORK – AtaiBeckley Inc., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, released additional results from its exploratory Phase 2a trial of EMP-01, an oral formulation ...
Industrial Hemp Market to Exceed $7B by 2031, Driven by Construction and Wellness
LOS ANGELES – The global industrial hemp market is on track to nearly double in value over the next five years, according to the latest report by Mordor Intelligence that projects the market to grow ...
Oklahoma Law Review Claims 280E No Longer Applies Post-Cannabis Rescheduling
TULSA – A forthcoming article in the Oklahoma Law Review contends that federal rescheduling of Cannabis to Schedule III would place the plant outside the reach of Internal Revenue Code Section 280E, potentially ending the ...
LEEF Brands Reaches Deal to Acquire Himalaya Vapor
VANCOUVER – LEEF Brands Inc. entered into an agreement and plan of merger to acquire Standard Holdings Inc. the parent company of Himalaya Vapor, a California concentrates producer known for its full-spectrum cartridges and live ...
ATACH Publishes Report on Updated Hemp Regulations
WASHINGTON – Federal lawmakers moved last year to shut down a major loophole in hemp rules, and the American Trade Association for Cannabis and Hemp (ATACH) has now delivered a clear-eyed examination outlining the regulatory ...
Seed Junky Genetics Announces MINNTZ Return
LOS ANGELES – JBeezy, the founder of Seed Junky Genetics, confirmed that the MINNTZ® brand is officially returning as an independent line following a new agreement with Michigan-based HNG Solutions, LLC. The partnership will put ...
President Trump Signs EO to Accelerate Psychedelic Research and Access
WASHINGTON – President Donald Trump signed an executive order directing federal agencies to speed up reviews of certain psychedelic compounds and open new pathways for patient access as treatments for serious mental health disorders like ...
Trump Fast Tracks Psychedelic Research
WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen ...
Decibel Reports Q4 and FY 2025 Financial Results
CALGARY – Decibel Cannabis Company Inc. posted audited results for the fourth quarter and full year ended December 31, 2025, showing overall revenue growth driven largely by its international operations. Net revenue for the year ...
Five Years After Legalization, Virginia Still Isn’t Ready—But It’s Getting Closer
Virginia’s Cannabis market has been “legal” on paper for years. In practice, it’s been stuck in neutral—possession allowed, but no regulated retail system to match it. That may finally be shifting. The latest move out ...
Tilray Acquires Lyphe Group, Expands UK Medical Cannabis Reach
LONDON – Tilray Brands Inc. has acquired the Lyphe Group, a British operator of online medical Cannabis clinics and a digital pharmacy platform. The deal adds a network that has treated more than 16,000 patients ...
Compass Pathways Opens U.S. Grant Program for Psychedelic Therapy Training
NEW YORK – Compass Pathways PLC ADR announced a new grant program inviting U.S.-based organizations to develop training content for healthcare providers who could deliver its investigational COMP360 psilocybin treatment if regulators approve it. The ...
